Testosterone Global Patent Coverage & Expiry Overview

Track protection status across key markets to assess launch feasibility.

Start your free 7-Day Trial! Book a demo to explore our global patent data.

It is formulated by 32 pharmaceutical companies such as HIKMA, ELI LILLY AND CO, ENDO OPERATIONS and others. It is marketed under 16 brand names, including TESTOSTERONE CYPIONATE, AXIRON, FORTESTA and others. Available in 26 different strengths, such as 200MG/ML, 100MG/ML, 30MG/1.5ML ACTUATION and others, and administered through 10 routes including INJECTABLE;INJECTION, SOLUTION, METERED;TRANSDERMAL, GEL, METERED;TRANSDERMAL and others.

Strategic Dashboard

info

insightsStrategic Insights

Sourcing & Feasibility

check_circle API availability: autorenew Loading API feasibility...

groups Licensing: 32 potential partners

calendar_todayUS Launch window: autorenew Loading launch window...

timeline Key Patent Barrier & Expiry Timeline

autorenew Loading patent barriers...

factoryGeneric Manufacturer Snapshot

autorenew Loading manufacturers...

gavelRisk & Opportunity Summary

dangerous Risk: autorenew Loading risk analysis...

watch_later Watch: autorenew Loading watch analysis...

rocket_launch Opportunity: autorenew Loading opportunity analysis...

Country

flag

Legal Status

gavel

Expiry From

calendar_today

Expiry To

calendar_today

Access Global Patent Data

Stay ahead with worldwide patent expiry and latest updates.

✓ Comprehensive global patent expiry timelines

✓ Full patent family details and status updates

Unlock Global Patents

Orange Book Drug Approval Timeline

FDA approval history for this ingredient

NDA (New Drug Application) ANDA (Generic Application)

Access Global Exclusivity and Patent Expiry Extensions

Stay ahead with worldwide patent expiry insights, exclusivity data, and latest updates.

✓ Comprehensive global patent expiry timelines

✓ Full patent family details and status updates

✓ Latest exclusivity data and extensions

Unlock Global Access

US Orange Book Patents Expiration Timeline

Key expiration dates for US patents covering this ingredient

View Global Patents Expiration Timeline

Stay ahead with worldwide patent expiry insights, market data, and research updates.

✓ Comprehensive global patent expiry timelines

✓ Full patent family details and status updates

Unlock Global Patent Timeline

Orange Book Drug Strengths

Latest drug strengths approved by FDA

Strength	Route of Administration	Companies	Latest Approval Date

Orange Book Patents

Patents approved by the FDA for the ingredient

	Patent Number	Publication Date	Legal Status	Patent Expiry Date
{"application_id":"71496","ingredient":"TESTOSTERONE ENANTHATE","trade_name":"XYOSTED (AUTOINJECTOR)","family_id":"277272c15e8842a9bcdd","publication_number":"US9629959B2","cleaned_patent_number":"9629959","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2026-01-24","publication_date":"2017-04-25","legal_status":"Granted"}	US9629959B2 Formulation	25 Apr, 2017	Granted	24 Jan, 2026
{"application_id":"71494","ingredient":"TESTOSTERONE ENANTHATE","trade_name":"XYOSTED (AUTOINJECTOR)","family_id":"277272c15e8842a9bcdd","publication_number":"US8562564B2","cleaned_patent_number":"8562564","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2026-01-24","publication_date":"2013-10-22","legal_status":"Granted"}	US8562564B2 Formulation	22 Oct, 2013	Granted	24 Jan, 2026
{"application_id":"71497","ingredient":"TESTOSTERONE ENANTHATE","trade_name":"XYOSTED (AUTOINJECTOR)","family_id":"277272c15e8842a9bcdd","publication_number":"US10478560B2","cleaned_patent_number":"10478560","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2026-01-24","publication_date":"2019-11-19","legal_status":"Granted"}	US10478560B2 Formulation	19 Nov, 2019	Granted	24 Jan, 2026
{"application_id":"71495","ingredient":"TESTOSTERONE ENANTHATE","trade_name":"XYOSTED (AUTOINJECTOR)","family_id":"277272c15e8842a9bcdd","publication_number":"US9180259B2","cleaned_patent_number":"9180259","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2026-01-24","publication_date":"2015-11-10","legal_status":"Granted"}	US9180259B2 Formulation	10 Nov, 2015	Granted	24 Jan, 2026
{"application_id":"71479","ingredient":"TESTOSTERONE ENANTHATE","trade_name":"XYOSTED (AUTOINJECTOR)","family_id":"277272c15e8842a9bcdd","publication_number":"US9533102B2","cleaned_patent_number":"9533102","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2026-01-24","publication_date":"2017-01-03","legal_status":"Granted"}	US9533102B2 Formulation	03 Jan, 2017	Granted	24 Jan, 2026
{"application_id":"71499","ingredient":"TESTOSTERONE ENANTHATE","trade_name":"XYOSTED (AUTOINJECTOR)","family_id":"2dc48a0f7fc946c5af58","publication_number":"US11446441B2","cleaned_patent_number":"11446441","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2026-01-24","publication_date":"2022-09-20","legal_status":"Granted"}	US11446441B2 Formulation	20 Sep, 2022	Granted	24 Jan, 2026
{"application_id":"48601","ingredient":"TESTOSTERONE UNDECANOATE","trade_name":"JATENZO","family_id":"3b15355c009648899b38","publication_number":"US11179402B2","cleaned_patent_number":"11179402","drug_product_flag":"Y","drug_substance_flag":"Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2026-04-14","publication_date":"2021-11-23","legal_status":"Granted"}	US11179402B2 Molecular Formulation	23 Nov, 2021	Granted	14 Apr, 2026
{"application_id":"70242","ingredient":"TESTOSTERONE","trade_name":"AXIRON","family_id":"ccc53f5f59614042be7c","publication_number":"US9180194B2","cleaned_patent_number":"9180194","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2026-06-02","publication_date":"2015-11-10","legal_status":"Expired"}	US9180194B2	10 Nov, 2015	Expired	02 Jun, 2026
{"application_id":"70259","ingredient":"TESTOSTERONE","trade_name":"AXIRON","family_id":"ccc53f5f59614042be7c","publication_number":"US8993520B2","cleaned_patent_number":"8993520","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2026-06-02","publication_date":"2015-03-31","legal_status":"Expired"}	US8993520B2	31 Mar, 2015	Expired	02 Jun, 2026
{"application_id":"71493","ingredient":"TESTOSTERONE ENANTHATE","trade_name":"XYOSTED (AUTOINJECTOR)","family_id":"277272c15e8842a9bcdd","publication_number":"US8021335B2","cleaned_patent_number":"8021335","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2026-10-04","publication_date":"2011-09-20","legal_status":"Granted"}	US8021335B2 Formulation	20 Sep, 2011	Granted	04 Oct, 2026
{"application_id":"59140","ingredient":"TESTOSTERONE","trade_name":"ANDROGEL","family_id":"4cc5adabf44a4dc4b91b","publication_number":"US8729057B2","cleaned_patent_number":"8729057","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2026-10-12","publication_date":"2014-05-20","legal_status":"Granted"}	US8729057B2 Formulation	20 May, 2014	Granted	12 Oct, 2026
{"application_id":"59143","ingredient":"TESTOSTERONE","trade_name":"ANDROGEL","family_id":"4cc5adabf44a4dc4b91b","publication_number":"US8759329B2","cleaned_patent_number":"8759329","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2026-10-12","publication_date":"2014-06-24","legal_status":"Patented case"}	US8759329B2 Formulation	24 Jun, 2014	Patented case	12 Oct, 2026
{"application_id":"59142","ingredient":"TESTOSTERONE","trade_name":"ANDROGEL","family_id":"4cc5adabf44a4dc4b91b","publication_number":"US8754070B2","cleaned_patent_number":"8754070","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2026-10-12","publication_date":"2014-06-17","legal_status":"Granted"}	US8754070B2 Formulation	17 Jun, 2014	Granted	12 Oct, 2026
{"application_id":"59141","ingredient":"TESTOSTERONE","trade_name":"ANDROGEL","family_id":"4cc5adabf44a4dc4b91b","publication_number":"US8741881B2","cleaned_patent_number":"8741881","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2026-10-12","publication_date":"2014-06-03","legal_status":"Granted"}	US8741881B2	03 Jun, 2014	Granted	12 Oct, 2026
{"application_id":"59139","ingredient":"TESTOSTERONE","trade_name":"ANDROGEL","family_id":"4cc5adabf44a4dc4b91b","publication_number":"US8486925B2","cleaned_patent_number":"8486925","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2026-10-12","publication_date":"2013-07-16","legal_status":"Patented case"}	US8486925B2 Formulation	16 Jul, 2013	Patented case	12 Oct, 2026
{"application_id":"59138","ingredient":"TESTOSTERONE","trade_name":"ANDROGEL","family_id":"4cc5adabf44a4dc4b91b","publication_number":"US8466138B2","cleaned_patent_number":"8466138","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2026-10-12","publication_date":"2013-06-18","legal_status":"Granted"}	US8466138B2	18 Jun, 2013	Granted	12 Oct, 2026
{"application_id":"59099","ingredient":"TESTOSTERONE","trade_name":"ANDROGEL","family_id":"4cc5adabf44a4dc4b91b","publication_number":"US8466137B2","cleaned_patent_number":"8466137","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2026-10-12","publication_date":"2013-06-18","legal_status":"Patented case"}	US8466137B2	18 Jun, 2013	Patented case	12 Oct, 2026
{"application_id":"59137","ingredient":"TESTOSTERONE","trade_name":"ANDROGEL","family_id":"4cc5adabf44a4dc4b91b","publication_number":"US8466136B2","cleaned_patent_number":"8466136","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2026-10-12","publication_date":"2013-06-18","legal_status":"Granted"}	US8466136B2 Formulation	18 Jun, 2013	Granted	12 Oct, 2026
{"application_id":"48603","ingredient":"TESTOSTERONE UNDECANOATE","trade_name":"JATENZO","family_id":"3b15355c009648899b38","publication_number":"US11331325B2","cleaned_patent_number":"11331325","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-01-06","publication_date":"2022-05-17","legal_status":"Granted"}	US11331325B2	17 May, 2022	Granted	06 Jan, 2027
{"application_id":"70298","ingredient":"TESTOSTERONE","trade_name":"AXIRON","family_id":"489a3db6e76b4a128358","publication_number":"US8419307B2","cleaned_patent_number":"8419307","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-02-26","publication_date":"2013-04-16","legal_status":"Granted"}	US8419307B2	16 Apr, 2013	Granted	26 Feb, 2027
{"application_id":"70299","ingredient":"TESTOSTERONE","trade_name":"AXIRON","family_id":"489a3db6e76b4a128358","publication_number":"US9289586B2","cleaned_patent_number":"9289586","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-02-26","publication_date":"2016-03-22","legal_status":"Granted"}	US9289586B2	22 Mar, 2016	Granted	26 Feb, 2027
{"application_id":"70284","ingredient":"TESTOSTERONE","trade_name":"AXIRON","family_id":"489a3db6e76b4a128358","publication_number":"US8807861B2","cleaned_patent_number":"8807861","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-02-26","publication_date":"2014-08-19","legal_status":"Granted"}	US8807861B2 Formulation	19 Aug, 2014	Granted	26 Feb, 2027
{"application_id":"62153","ingredient":"TESTOSTERONE UNDECANOATE","trade_name":"AVEED","family_id":"52a504ff3d384791b4de","publication_number":"US7718640B2","cleaned_patent_number":"7718640","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-03-14","publication_date":"2010-05-18","legal_status":"Granted"}	US7718640B2 Formulation	18 May, 2010	Granted	14 Mar, 2027
{"application_id":"62112","ingredient":"TESTOSTERONE UNDECANOATE","trade_name":"AVEED","family_id":"52a504ff3d384791b4de","publication_number":"US8338395B2","cleaned_patent_number":"8338395","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-05-08","publication_date":"2012-12-25","legal_status":"Granted"}	US8338395B2	25 Dec, 2012	Granted	08 May, 2027
{"application_id":"70258","ingredient":"TESTOSTERONE","trade_name":"AXIRON","family_id":"ccc53f5f59614042be7c","publication_number":"US8435944B2","cleaned_patent_number":"8435944","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-09-27","publication_date":"2013-05-07","legal_status":"Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362"}	US8435944B2	07 May, 2013	Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362	27 Sep, 2027
{"application_id":"51495","ingredient":"TESTOSTERONE UNDECANOATE","trade_name":"TLANDO","family_id":"d4d57caffe0344ee825f","publication_number":"US8778922B2","cleaned_patent_number":"8778922","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2029-01-08","publication_date":"2014-07-15","legal_status":"Granted"}	US8778922B2 Formulation	15 Jul, 2014	Granted	08 Jan, 2029
{"application_id":"51496","ingredient":"TESTOSTERONE UNDECANOATE","trade_name":"TLANDO","family_id":"d4d57caffe0344ee825f","publication_number":"US8865695B2","cleaned_patent_number":"8865695","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2029-01-08","publication_date":"2014-10-21","legal_status":"Granted"}	US8865695B2	21 Oct, 2014	Granted	08 Jan, 2029
{"application_id":"51470","ingredient":"TESTOSTERONE UNDECANOATE","trade_name":"TLANDO","family_id":"d4d57caffe0344ee825f","publication_number":"US11304960B2","cleaned_patent_number":"11304960","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2029-01-08","publication_date":"2022-04-19","legal_status":"Granted"}	US11304960B2 Formulation	19 Apr, 2022	Granted	08 Jan, 2029
{"application_id":"48595","ingredient":"TESTOSTERONE UNDECANOATE","trade_name":"JATENZO","family_id":"3b15355c009648899b38","publication_number":"US8241664B2","cleaned_patent_number":"8241664","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2029-03-29","publication_date":"2012-08-14","legal_status":"Granted"}	US8241664B2 Formulation	14 Aug, 2012	Granted	29 Mar, 2029
{"application_id":"79479","ingredient":"TESTOSTERONE ENANTHATE","trade_name":"XYOSTED (AUTOINJECTOR)","family_id":"c339f12d052b4dafa53f","publication_number":"US11497753B2","cleaned_patent_number":"11497753","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-03-19","publication_date":"2022-11-15","legal_status":"Granted"}	US11497753B2 Formulation	15 Nov, 2022	Granted	19 Mar, 2030
{"application_id":"48596","ingredient":"TESTOSTERONE UNDECANOATE","trade_name":"JATENZO","family_id":"3b15355c009648899b38","publication_number":"US8778916B2","cleaned_patent_number":"8778916","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-04-12","publication_date":"2014-07-15","legal_status":"Granted"}	US8778916B2 Formulation	15 Jul, 2014	Granted	12 Apr, 2030
{"application_id":"48616","ingredient":"TESTOSTERONE UNDECANOATE","trade_name":"JATENZO","family_id":"f55405ceebef4969997a","publication_number":"US11426416B2","cleaned_patent_number":"11426416","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-04-12","publication_date":"2022-08-30","legal_status":"Granted"}	US11426416B2	30 Aug, 2022	Granted	12 Apr, 2030
{"application_id":"48599","ingredient":"TESTOSTERONE UNDECANOATE","trade_name":"JATENZO","family_id":"3b15355c009648899b38","publication_number":"US10543219B2","cleaned_patent_number":"10543219","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-04-12","publication_date":"2020-01-28","legal_status":"Granted"}	US10543219B2	28 Jan, 2020	Granted	12 Apr, 2030
{"application_id":"48602","ingredient":"TESTOSTERONE UNDECANOATE","trade_name":"JATENZO","family_id":"3b15355c009648899b38","publication_number":"US11179403B2","cleaned_patent_number":"11179403","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-04-12","publication_date":"2021-11-23","legal_status":"Granted"}	US11179403B2	23 Nov, 2021	Granted	12 Apr, 2030
{"application_id":"48600","ingredient":"TESTOSTERONE UNDECANOATE","trade_name":"JATENZO","family_id":"3b15355c009648899b38","publication_number":"US10617696B2","cleaned_patent_number":"10617696","drug_product_flag":"Y","drug_substance_flag":"Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-04-12","publication_date":"2020-04-14","legal_status":"Granted"}	US10617696B2 Molecular Formulation	14 Apr, 2020	Granted	12 Apr, 2030
{"application_id":"51520","ingredient":"TESTOSTERONE UNDECANOATE","trade_name":"TLANDO","family_id":"5979b9ca1253408d9183","publication_number":"US10226473B2","cleaned_patent_number":"10226473","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-11-30","publication_date":"2019-03-12","legal_status":"Granted"}	US10226473B2	12 Mar, 2019	Granted	30 Nov, 2030
{"application_id":"51545","ingredient":"TESTOSTERONE UNDECANOATE","trade_name":"TLANDO","family_id":"ec01df96ea56487dad4a","publication_number":"US11433083B2","cleaned_patent_number":"11433083","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-11-30","publication_date":"2022-09-06","legal_status":"Granted"}	US11433083B2	06 Sep, 2022	Granted	30 Nov, 2030
{"application_id":"51527","ingredient":"TESTOSTERONE UNDECANOATE","trade_name":"TLANDO","family_id":"5979b9ca1253408d9183","publication_number":"US9949985B2","cleaned_patent_number":"9949985","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-11-30","publication_date":"2018-04-24","legal_status":"Granted"}	US9949985B2	24 Apr, 2018	Granted	30 Nov, 2030
{"application_id":"51533","ingredient":"TESTOSTERONE UNDECANOATE","trade_name":"TLANDO","family_id":"5979b9ca1253408d9183","publication_number":"US11364249B2","cleaned_patent_number":"11364249","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-11-30","publication_date":"2022-06-21","legal_status":"Granted"}	US11364249B2	21 Jun, 2022	Granted	30 Nov, 2030
{"application_id":"51526","ingredient":"TESTOSTERONE UNDECANOATE","trade_name":"TLANDO","family_id":"5979b9ca1253408d9183","publication_number":"US9943527B2","cleaned_patent_number":"9943527","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-11-30","publication_date":"2018-04-17","legal_status":"Granted"}	US9943527B2	17 Apr, 2018	Granted	30 Nov, 2030
{"application_id":"51528","ingredient":"TESTOSTERONE UNDECANOATE","trade_name":"TLANDO","family_id":"5979b9ca1253408d9183","publication_number":"US10716794B2","cleaned_patent_number":"10716794","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-11-30","publication_date":"2020-07-21","legal_status":"Granted"}	US10716794B2	21 Jul, 2020	Granted	30 Nov, 2030
{"application_id":"51532","ingredient":"TESTOSTERONE UNDECANOATE","trade_name":"TLANDO","family_id":"5979b9ca1253408d9183","publication_number":"US11311555B2","cleaned_patent_number":"11311555","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-11-30","publication_date":"2022-04-26","legal_status":"Granted"}	US11311555B2	26 Apr, 2022	Granted	30 Nov, 2030
{"application_id":"48578","ingredient":"TESTOSTERONE UNDECANOATE","trade_name":"JATENZO","family_id":"3b15355c009648899b38","publication_number":"US8492369B2","cleaned_patent_number":"8492369","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-12-20","publication_date":"2013-07-23","legal_status":"Granted"}	US8492369B2 Formulation	23 Jul, 2013	Granted	20 Dec, 2030
{"application_id":"105490","ingredient":"TESTOSTERONE UNDECANOATE","trade_name":"KYZATREX","family_id":"907a935883ba43309fff","publication_number":"US10576090B2","cleaned_patent_number":"10576090","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-12-31","publication_date":"2020-03-03","legal_status":"Granted"}	US10576090B2 Formulation	03 Mar, 2020	Granted	31 Dec, 2030
{"application_id":"105475","ingredient":"TESTOSTERONE UNDECANOATE","trade_name":"KYZATREX","family_id":"907a935883ba43309fff","publication_number":"US10576089B2","cleaned_patent_number":"10576089","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-12-31","publication_date":"2020-03-03","legal_status":"Granted"}	US10576089B2 Formulation	03 Mar, 2020	Granted	31 Dec, 2030
{"application_id":"105495","ingredient":"TESTOSTERONE UNDECANOATE","trade_name":"KYZATREX","family_id":"3109bb82aa194aa58c89","publication_number":"US11590146B2","cleaned_patent_number":"11590146","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-12-31","publication_date":"2023-02-28","legal_status":"Granted"}	US11590146B2 Formulation	28 Feb, 2023	Granted	31 Dec, 2030
{"application_id":"71529","ingredient":"TESTOSTERONE ENANTHATE","trade_name":"XYOSTED (AUTOINJECTOR)","family_id":"b7881c3340204d44aa15","publication_number":"US10279131B2","cleaned_patent_number":"10279131","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2031-07-31","publication_date":"2019-05-07","legal_status":"Granted"}	US10279131B2 Formulation	07 May, 2019	Granted	31 Jul, 2031
{"application_id":"71536","ingredient":"TESTOSTERONE ENANTHATE","trade_name":"XYOSTED (AUTOINJECTOR)","family_id":"4c73b92d2c45454a85a2","publication_number":"US11446440B2","cleaned_patent_number":"11446440","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2031-08-21","publication_date":"2022-09-20","legal_status":"Granted"}	US11446440B2 Formulation	20 Sep, 2022	Granted	21 Aug, 2031
{"application_id":"71530","ingredient":"TESTOSTERONE ENANTHATE","trade_name":"XYOSTED (AUTOINJECTOR)","family_id":"b7881c3340204d44aa15","publication_number":"US10357609B2","cleaned_patent_number":"10357609","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2031-08-21","publication_date":"2019-07-23","legal_status":"Granted"}	US10357609B2 Formulation	23 Jul, 2019	Granted	21 Aug, 2031
{"application_id":"71533","ingredient":"TESTOSTERONE ENANTHATE","trade_name":"XYOSTED (AUTOINJECTOR)","family_id":"b7881c3340204d44aa15","publication_number":"US10905827B2","cleaned_patent_number":"10905827","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2031-08-21","publication_date":"2021-02-02","legal_status":"Granted"}	US10905827B2 Formulation	02 Feb, 2021	Granted	21 Aug, 2031
{"application_id":"105496","ingredient":"TESTOSTERONE UNDECANOATE","trade_name":"KYZATREX","family_id":"3109bb82aa194aa58c89","publication_number":"US11617758B2","cleaned_patent_number":"11617758","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2033-03-15","publication_date":"2023-04-04","legal_status":"Granted"}	US11617758B2 Formulation	04 Apr, 2023	Granted	15 Mar, 2033
{"application_id":"71531","ingredient":"TESTOSTERONE ENANTHATE","trade_name":"XYOSTED (AUTOINJECTOR)","family_id":"b7881c3340204d44aa15","publication_number":"US10821072B2","cleaned_patent_number":"10821072","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2033-06-04","publication_date":"2020-11-03","legal_status":"Granted"}	US10821072B2 Formulation	03 Nov, 2020	Granted	04 Jun, 2033
{"application_id":"80362","ingredient":"TESTOSTERONE ENANTHATE","trade_name":"XYOSTED (AUTOINJECTOR)","family_id":"ed1efe55eeb2480c8f41","publication_number":"US11844804B2","cleaned_patent_number":"11844804","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2033-06-04","publication_date":"2023-12-19","legal_status":"Granted"}	US11844804B2	19 Dec, 2023	Granted	04 Jun, 2033
{"application_id":"71532","ingredient":"TESTOSTERONE ENANTHATE","trade_name":"XYOSTED (AUTOINJECTOR)","family_id":"b7881c3340204d44aa15","publication_number":"US10881798B2","cleaned_patent_number":"10881798","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-02-11","publication_date":"2021-01-05","legal_status":"Granted"}	US10881798B2 Formulation	05 Jan, 2021	Granted	11 Feb, 2034
{"application_id":"59228","ingredient":"TESTOSTERONE","trade_name":"VOGELXO","family_id":"a3cc743223b647de8b31","publication_number":"US9662340B2","cleaned_patent_number":"9662340","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-02-11","publication_date":"2017-05-30","legal_status":"Granted"}	US9662340B2 Formulation	30 May, 2017	Granted	11 Feb, 2034
{"application_id":"59227","ingredient":"TESTOSTERONE","trade_name":"VOGELXO","family_id":"a3cc743223b647de8b31","publication_number":"US9295675B2","cleaned_patent_number":"9295675","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-02-11","publication_date":"2016-03-29","legal_status":"Granted"}	US9295675B2 Formulation	29 Mar, 2016	Granted	11 Feb, 2034
{"application_id":"59220","ingredient":"TESTOSTERONE","trade_name":"VOGELXO","family_id":"a3cc743223b647de8b31","publication_number":"US8785426B1","cleaned_patent_number":"8785426","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-02-11","publication_date":"2014-07-22","legal_status":"Granted"}	US8785426B2 Formulation	22 Jul, 2014	Granted	11 Feb, 2034
{"application_id":"59076","ingredient":"TESTOSTERONE","trade_name":"NATESTO","family_id":"bb6497c24a734325b6ac","publication_number":"US11090312B2","cleaned_patent_number":"11090312","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-03-17","publication_date":"2021-08-17","legal_status":"Granted"}	US11090312B2	17 Aug, 2021	Granted	17 Mar, 2034
{"application_id":"80366","ingredient":"TESTOSTERONE ENANTHATE","trade_name":"XYOSTED (AUTOINJECTOR)","family_id":"664bdb44bf5a4ee18829","publication_number":"US11160751B2","cleaned_patent_number":"11160751","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-10-07","publication_date":"2021-11-02","legal_status":"Granted"}	US11160751B2 Formulation	02 Nov, 2021	Granted	07 Oct, 2034
{"application_id":"80356","ingredient":"TESTOSTERONE ENANTHATE","trade_name":"XYOSTED (AUTOINJECTOR)","family_id":"ed1efe55eeb2480c8f41","publication_number":"US10912782B2","cleaned_patent_number":"10912782","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-02-19","publication_date":"2021-02-09","legal_status":"Granted"}	US10912782B2 Formulation	09 Feb, 2021	Granted	19 Feb, 2035
{"application_id":"80361","ingredient":"TESTOSTERONE ENANTHATE","trade_name":"XYOSTED (AUTOINJECTOR)","family_id":"ed1efe55eeb2480c8f41","publication_number":"US10238662B2","cleaned_patent_number":"10238662","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-02-19","publication_date":"2019-03-26","legal_status":"Granted"}	US10238662B2 Formulation	26 Mar, 2019	Granted	19 Feb, 2035
{"application_id":"71538","ingredient":"TESTOSTERONE ENANTHATE","trade_name":"XYOSTED (AUTOINJECTOR)","family_id":"4a343706e157479f8119","publication_number":"US11813435B2","cleaned_patent_number":"11813435","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-02-25","publication_date":"2023-11-14","legal_status":"Granted"}	US11813435B2 Formulation	14 Nov, 2023	Granted	25 Feb, 2035
{"application_id":"80376","ingredient":"TESTOSTERONE ENANTHATE","trade_name":"XYOSTED (AUTOINJECTOR)","family_id":"f091767e066d46788ecd","publication_number":"US11191908B2","cleaned_patent_number":"11191908","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-10-18","publication_date":"2021-12-07","legal_status":"Granted"}	US11191908B2 Formulation	07 Dec, 2021	Granted	18 Oct, 2035
{"application_id":"71527","ingredient":"TESTOSTERONE ENANTHATE","trade_name":"XYOSTED (AUTOINJECTOR)","family_id":"b7881c3340204d44aa15","publication_number":"US9744302B2","cleaned_patent_number":"9744302","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-11-19","publication_date":"2017-08-29","legal_status":"Granted"}	US9744302B2 Formulation	29 Aug, 2017	Granted	19 Nov, 2035
{"application_id":"71528","ingredient":"TESTOSTERONE ENANTHATE","trade_name":"XYOSTED (AUTOINJECTOR)","family_id":"b7881c3340204d44aa15","publication_number":"US9950125B2","cleaned_patent_number":"9950125","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-09-04","publication_date":"2018-04-24","legal_status":"Granted"}	US9950125B2 Formulation	24 Apr, 2018	Granted	04 Sep, 2036
{"application_id":"111287","ingredient":"TESTOSTERONE UNDECANOATE","trade_name":"TLANDO","family_id":"9719f9a63deb4bb993a8","publication_number":"US11559530B2","cleaned_patent_number":"11559530","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2037-11-28","publication_date":"2023-01-24","legal_status":"Granted"}	US11559530B2	24 Jan, 2023	Granted	28 Nov, 2037
{"application_id":"80388","ingredient":"TESTOSTERONE ENANTHATE","trade_name":"XYOSTED (AUTOINJECTOR)","family_id":"8717823215dd42b9a05f","publication_number":"US10646495B2","cleaned_patent_number":"10646495","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2038-08-30","publication_date":"2020-05-12","legal_status":"Granted"}	US10646495B2 Formulation	12 May, 2020	Granted	30 Aug, 2038
{"application_id":"242098","ingredient":"TESTOSTERONE UNDECANOATE","trade_name":"TLANDO","family_id":"","publication_number":"US12310978B2","cleaned_patent_number":"12310978","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2039-02-21","publication_date":"2025-05-27","legal_status":"Granted"}	US12310978B2	27 May, 2025	Granted	21 Feb, 2039
{"application_id":"71553","ingredient":"TESTOSTERONE CYPIONATE","trade_name":"AZMIRO","family_id":"067f741e39d5445f8b6d","publication_number":"US11311554B2","cleaned_patent_number":"11311554","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2039-03-25","publication_date":"2022-04-26","legal_status":"Granted"}	US11311554B2 Formulation	26 Apr, 2022	Granted	25 Mar, 2039
{"application_id":"71554","ingredient":"TESTOSTERONE CYPIONATE","trade_name":"AZMIRO","family_id":"ba021ed850274b73830a","publication_number":"US11642355B2","cleaned_patent_number":"11642355","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2039-03-25","publication_date":"2023-05-09","legal_status":"Granted"}	US11642355B2 Formulation	09 May, 2023	Granted	25 Mar, 2039
{"application_id":"115711","ingredient":"TESTOSTERONE CYPIONATE","trade_name":"AZMIRO","family_id":"ba021ed850274b73830a","publication_number":"US2023248742A1","cleaned_patent_number":"12138271","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2039-03-25","publication_date":"2023-08-10","legal_status":"Granted"}	US12138271B2 Formulation	10 Aug, 2023	Granted	25 Mar, 2039
{"application_id":"111270","ingredient":"TESTOSTERONE UNDECANOATE","trade_name":"JATENZO","family_id":"88f7db6c30824e9484f1","publication_number":"US11564933B2","cleaned_patent_number":"11564933","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2039-04-12","publication_date":"2023-01-31","legal_status":"Granted"}	US11564933B2	31 Jan, 2023	Granted	12 Apr, 2039
{"application_id":"124161","ingredient":"TESTOSTERONE UNDECANOATE","trade_name":"TLANDO","family_id":"","publication_number":"US12011503B1","cleaned_patent_number":"12011503","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2040-10-16","publication_date":"2024-06-18","legal_status":"Granted"}	US12011503B2 Formulation	18 Jun, 2024	Granted	16 Oct, 2040
{"application_id":"109351","ingredient":"TESTOSTERONE UNDECANOATE","trade_name":"TLANDO","family_id":"fb28e2c8dfff405eb14c","publication_number":"US11464735B2","cleaned_patent_number":"11464735","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2041-04-28","publication_date":"2022-10-11","legal_status":"Granted"}	US11464735B2 Formulation	11 Oct, 2022	Granted	28 Apr, 2041

Recent Clinical Trials

Latest clinical trials and research studies for this ingredient

NCT ID	Title	Status	Phase	Conditions	Start Date	Completion Date

API Suppliers/Manufacturer (Branded/Generic companies)

Manufacturing Locations

Filter by Country

View Complete Supplier List

Unlock access to all suppliers of Testosterone

✓ Access a comprehensive list of global suppliers

✓ Get information on each supplier

Unlock Suppliers

Note: Patent expirations and exclusivity timelines are dynamic and may shift based on litigation, regulatory extensions, and maintenance filings. Regular monitoring is advised.